Cargando…
Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry
Pharmacogenomics represents a potentially powerful enhancement to the current standard of care for psychiatric patients. However, a variety of biological and technical challenges must be addressed in order to provide adequate clinical decision support for personalized prescribing and dosing based on...
Autores principales: | Jarvis, Joseph P., Peter, Arul Prakasam, Shaman, Jeffrey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595891/ https://www.ncbi.nlm.nih.gov/pubmed/31281270 http://dx.doi.org/10.3389/fpsyt.2019.00432 |
Ejemplares similares
-
Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program
por: Jarvis, Joseph P., et al.
Publicado: (2022) -
The Three Ps: Psychiatry, Pharmacy, and Pharmacogenomics, a Brief Report From New Zealand
por: Maggo, Simran D.S., et al.
Publicado: (2019) -
Copy number polymorphisms and anticancer pharmacogenomics
por: Gamazon, Eric R, et al.
Publicado: (2011) -
Early Insights From a Pharmacogenomic-Enriched Comprehensive Medication Management Program Implementation in an Adult Employee Population
por: Keogh, Murray, et al.
Publicado: (2022) -
Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype
por: Marcos-Vadillo, Elena, et al.
Publicado: (2022)